Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
---|---|---|---|
USD 63 Billion | USD 114 Billion | 6.81% | 2023 |
The global pet healthcare market size was evaluated at $63 billion in 2023 and is slated to hit $114 billion by the end of 2032 with a CAGR of nearly 6.81% between 2024 and 2032.
Growing awareness about animal welfare has increased the use and popularity of pet healthcare products globally. A large number of pet healthcare products are easily available in supermarkets/hypermarkets and retail stores. Pet lovers as well as pet owners are aware of their pets getting infected from various infections and hence they purchase pet healthcare products as well as get their pets diagnosed with the help of veterinary doctors.
Surging end-user tilt towards healthy pet diet to boost the global market trends over 2024-2032
Growing customer preference toward healthy diets for pets has transformed into humungous growth of the global pet healthcare market. A surge in the meat & milk supply across the globe will pave the way for massive growth of the market globally. A rise in foodborne and zoonotic ailments along with an increase in the adoption of pets will steer the expansion of the global market. An increase in the vaccinations of pets along with easy availability of medicines for treating pets will embellish the expansion of the market across the globe. New product launches are projected to contribute majorly towards the expansion of the global market. For instance, in January 2024, Dong-A Pharmaceutical Company Limited, a Pharmaceutical Company, introduced Vetple, a premium pet healthcare product for cats and dogs available with personalized pet nutrition items. Reportedly, the new products include three food items for dogs & three new food products for cats that will take care of the mental & physical health of pets.
A surge in the costs of high-quality products can impede the expansion of the industry globally by 2032
An exponential increase in the price of high-quality pet healthcare products along with the scarce availability of raw components used for manufacturing these products can put brakes on the growth path of the global pet healthcare industry. Uncertainty of pet diseases such as diarrhea and abdominal pain can hinder global industry expansion.
Favorable government rules pertaining to healthcare of pets can create new avenues of growth for the global market
Supportive government laws related to pet healthcare along with improvement in the pet healthcare infrastructure facilities in emerging economies are anticipated to open new avenues of growth for the global pet healthcare market. In addition to this, the easy availability of improved medical treatment amenities for pets along with the rise in pet immunization programs carried out by the government is likely to boost the expansion of the market globally. Apart from this, an increase in research activities for veterinary research labs aimed at finding innovative treatments for foodborne & zoonotic diseases in pets will expand the scope of the global market demand.
Strict legislations about manufacture & selling of products can challenge the global industry surge by 2032
Stringent laws related to the production and sale of the products along with disruptions in the supply of the products can prove to be a daunting task in the growth of the global pet healthcare industry.
The global pet healthcare market is sectored into product type, pet type, distribution channel, and region.
In product type terms, the pet healthcare market across the globe is segregated into pet food products and veterinary care segments. Furthermore, the pet food segment, which acquired nearly 40% of the global market revenue in 2023, is predicted to record the fastest growth rate in the projected timeframe. The expansion of the segment in the assessment timeframe can be owing to the humungous intake of nutritious foods by pets. Additionally, easy access to various animal food products will embellish the expansion of the segment in the upcoming years
Based on the pet type, the global pet healthcare industry is sectored into dog and cat segments. Furthermore, the dog segment, which gathered a key share of the global industry in 2023, is predicted to lead the segment in the next couple of years. The segmental expansion during the period from 2024 to 2032 can be due to the friendly nature of dogs and the use of pet healthcare products for improving their health as they can help in preventing house robberies. Apart from this, dogs are easily humanized and trained, thereby steering the segmental surge.
Based on distribution channels, the pet healthcare market across the globe is bifurcated into online as well as offline segments. Moreover, the offline segment, which acquired nearly 47% of the global market earnings in 2023, is expected to register the fastest growth rate in the predicted timeline. The expansion of the segment in the forecast period can be due to the easy availability of pet healthcare product supplies in hypermarkets/supermarkets and retail stores.
Report Attributes | Report Details |
---|---|
Report Name | Pet Healthcare Market |
Market Size in 2023 | USD 63 Billion |
Market Forecast in 2032 | USD 114 Billion |
Growth Rate | CAGR of 6.81% |
Number of Pages | 207 |
Key Companies Covered | Boehringer Ingelheim GmbH, Zoetis Inc., Merck & Co. Inc., Vetoquinol S.A., Dechra Pharmaceuticals plc, Ceva Santé Animale, Elanco, Virbac, Mars Inc., IDEXX Laboratories Inc., and others. |
Segments Covered | By Product Type, By Pet Type, and By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
North America is forecast to maintain the leading position in the global pet healthcare market in the upcoming years
North America, which garnered nearly 71% of the global pet healthcare market earnings in 2023, is likely to be a leading region in the coming seven years. Apart from this, the regional market expansion over the anticipated timespan can be attributed to a rise in the expenditure on pet healthcare products by the populations in Canada and the U.S. In addition to this, a rise in the number of players manufacturing pet healthcare products in these countries will further prompt the regional market surge in the upcoming years.
Asia-Pacific pet healthcare industry is set to register the fastest rate of annual growth in the forecast timeline. The surge of the industry in the APAC zone can be a result of the massive presence of key players such as Nestle S.A. and Mars Inc. Apart from this, the presence of strong pet healthcare infrastructure in countries such as China and India will proliferate the size of the industry in the region.
The global pet healthcare market profiles key players such as:
By Product Type
By Pet Type
By Distribution Channel
FrequentlyAsked Questions
Growing awareness about animal welfare has increased the use and popularity of the pet healthcare products globally. A large number of pet healthcare products are easily available in the supermarkets/hypermarkets and retail stores.
The global pet healthcare market growth over forecast period can be owing to growing customer preference towards healthy diet for pets.
According to a study, the global pet healthcare industry size was $63 billion in 2023 and is projected to reach $114 billion by the end of 2032.
The global pet healthcare market is anticipated to record a CAGR of nearly 6.81% from 2024 to 2032.
The Asia-Pacific pet healthcare industry is set to register the fastest CAGR over the forecasting timeline owing to massive presence of key players such a Nestle S.A. and Mars Inc. Apart from this, presence of strong pet healthcare infrastructure in the countries such as China and India will proliferate the size of the industry in the region..
The global pet healthcare market is led by players such as Boehringer Ingelheim GmbH, Zoetis Inc., Merck & Co., Inc., Vetoquinol S.A., Dechra Pharmaceuticals plc, Ceva Santé Animale, Elanco, Virbac, Mars Inc., and IDEXX Laboratories, Inc. The market is highly fragmented with a large number of new players entering the market while the dominant players contributing minimally towards the global market profits.
The global pet healthcare market report covers the geographical market along with a comprehensive competitive landscape analysis. It also includes cash flow analysis, profit ratio analysis, market basket analysis, market attractiveness analysis, sentiment analysis, PESTEL analysis, trend analysis, SWOT analysis, trade area analysis, demand & supply analysis, Porter’s five force analysis, and value chain analysis.
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed